Developer docs
API playgroundTry for free, no card

Search company profiles

Cryosite

Full company profile

uuid003g7bd

Namestring
Cryosite
Legal namestring
Cryosite Limited
Websiteurl
cryosite.com
Company typeenum
Public
Founded yearint
2000
Descriptiontext

Cryosite Limited (ASX: CTE) is an Australian clinical trial depot services provider operating from a TGA-licensed, GMP-certified facility in South Granville, NSW. The company manages the end-to-end clinical trial supply chain for pharmaceutical companies, contract research organisations (CROs), and biotechnology firms, including importation of clinical materials, multi-temperature storage (controlled ambient 15–25°C, refrigerated 2–8°C, frozen -20°C, ultra-frozen -80°C, and cryogenic -196°C), distribution, secondary packaging, and reverse logistics including drug return and destruction. Cryosite operates one of Australia's largest single-site liquid nitrogen tank farms for cryogenic storage of cell and gene therapies, biological samples, and cell banks, supported by validated Warehouse Management and Quality Management Systems, 24/7 continuous temperature monitoring with automated alarm escalation, and RF barcode scanning for full chain-of-custody traceability. The company also retains a legacy cord blood storage portfolio from its origins as Australia's first private cord blood bank in 2000, including samples acquired from StemLife in 2016, though new cord blood collections ceased in 2017.

Cryosite generates revenue through managed-services contracts for clinical trial depot services and biological storage, supplemented by professional-services fees for importer of record work and TGA-licensed secondary packaging. Pricing is quote-based and tailored to client specifications rather than published on a tiered schedule. The company manages more than 6,000 shipments annually with a 99% on-time delivery rate and 90% temperature-controlled shipments, distributing across Australia, Asia Pacific, America, and Europe via carrier partnerships. Reported FY2026 unaudited financials show revenue of A$16.7 million and EBITDA of A$4.3 million, indicating profitable operations on a specialized-services base with a small headcount (11–50 employees).

The business is differentiated by a deep regulatory credential stack — TGA license, cGMP, PIC/S GMP, NSW Health wholesaler licensing, Department of Agriculture Approved Arrangement, and Australian cGMP for human blood, tissues, and cell therapies — which collectively raise barriers to entry for would-be depot competitors in the Australian market. Cryosite's go-to-market relies on direct B2B enterprise sales to pharma sponsors and CROs, supplemented by content marketing and industry association partnerships with ARCS and AusBiotech.

Short descriptiontext

Cryosite Limited (ASX: CTE) is an Australian TGA-licensed clinical trial depot services provider offering multi-temperature storage, distribution, secondary packaging, and importer of record services to pharmaceutical companies, CROs, and biotechnology firms from its Sydney facility, with specialization in cryogenic storage for cell and gene therapies.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersGranville, Australia
HQ citystring
Granville
HQ countrystring
Australia
HQ regionstring
Oceania
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
clinical trial logistics, biological storage services, cryogenic storage, cold chain management, pharmaceutical depot services
Industry5 codes
PRIMARYTLAIAIAC
Clinical Trials & Investigational Product (IP) Cold Chain Logistics
SECONDARYHLAGAGAK
Cold Chain Storage & Cryopreservation Services (LN2/Ultra-low)
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Biopharma Manufacturing Services (Biologics/Cell & Gene)
SECONDARYHLAAAJAN
Cold Chain, Cryopreservation & Biologics Storage/Handling Technologies
Healthcare & Life Sciences/Biotechnology & Biologics/Bioprocessing & Biomanufacturing Technology (upstream/downstream, single-use, analytics)
SECONDARYTLADAHAJ
Cryogenic / Ultra-Low Temperature Transport (e.g., dry ice, LN2)
Transportation & Logistics/Freight Transportation (Air, Maritime, Rail, Trucking)/Refrigerated & Temperature-Controlled Freight Transport
SECONDARYTLACAMAM
Dry Ice & Cryogenic (LN2) Handling and Transport Services
NAICS code1 code
  • Refrigerated Warehousing and Storage493120
SIC code2 codes
  • Wholesale-Medical, Dental & Hospital Equipment & Supplies5047
  • Services-Commercial Physical & Biological Research8731
Product category
Clinical Trial Logistics Services
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model4 records
1Clinical Trial Depot Services
TypeManaged Services
Description

Outsourced clinical trial logistics services including storage, distribution, returns management, and destruction of investigational products

cryosite.com
2Biological Storage Services
TypeManaged Services
Description

Cold, frozen, and cryogenic storage for biological materials including cord blood, cell banks, and tissue samples

cryosite.com
3Importer of Record Services
TypeProfessional Services
Description

Legal importation of clinical materials into Australia with permit applications support

cryosite.com
4Secondary Packaging Services
TypeProfessional Services
Description

TGA-licensed packaging services including re-labelling, re-packaging, and expiry extension

cryosite.com
Marketing channels3 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels2 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Operations, Infrastructure, Technology or R&D, Marketing or Sales
GTM typeB2B
B2B
Offering typeServices
Services
Core offering1 text field

Cryosite provides outsourced clinical trial depot services and biological storage from its TGA-licensed, GMP-certified facility in Sydney, Australia. The company manages the full clinical trial supply chain including importation, receipt, multi-temperature storage (controlled ambient, refrigerated, frozen, ultra-frozen, and cryogenic at -196°C), distribution, secondary packaging, and reverse logistics for pharmaceutical companies, CROs, and biotechnology firms. Additional services include cryogenic storage for cell and gene therapies, importer of record services, and drug return and destruction.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 3 values shown
  • 99% on-time delivery for shipments
+2 more records
Product overview1 text field

Cryosite is a clinical trials depot services company operating as a specialized third-party logistics (3PL) provider for the life sciences and biotechnology industries. The company offers a unified portfolio of services centered around clinical trial supply chain management, encompassing clinical trial logistics, biological storage (including cryogenic liquid nitrogen storage), cell and gene therapies depot services, cold chain management, temperature-sensitive distribution, and secondary packaging. Additional services include importer of record, drug return & destruction, and legacy cord blood storage. The company operates from a TGA-licensed and GMP-certified facility in Sydney, Australia, managing over 6,000 shipments annually with 90% temperature-controlled.

Product and service10 records
1Clinical Trial Logistics Services
CategoryClinical Trial Depot Services
Description

Specialised outsourced clinical trial logistics services managing the entire clinical trial supply chain from importation, receipt, ambient, cold, frozen, and liquid nitrogen storage for temperature-sensitive products, to distribution and reverse logistics management. Targeted at pharmaceutical companies, CROs, and biotechnology firms.

2Biological Storage
CategoryBiological Storage Services
Description

Frozen storage services for biological materials including cell banks (MCB, WCB), mesenchymal stromal cell therapies, TIL therapies, HPC therapies, vaccines, tissue samples, and blood products at various temperature ranges from -25°C to -196°C. For biotechnology and pharmaceutical companies.

3Cell & Gene Therapies Depot Services
CategoryCell and Gene Therapy Logistics
Description

Depot services specifically designed for cell and gene therapies, providing cryogenic storage, chain of custody management, and logistics support for these advanced therapeutic modalities. Targeted at biotechnology companies developing advanced therapies.

4Liquid Nitrogen Storage
CategoryCryogenic Storage Services
Description

Cryogenic liquid nitrogen storage solutions maintaining temperatures at -196°C for preserving biological materials, cell and gene therapies, with advanced cryogenic monitoring technology. For pharmaceutical, biotech, and research organisations.

5Importer of Record Services
CategoryRegulatory and Import Services
Description

Expert importer of record services ensuring legal importation of clinical materials into Australia, including permit applications for Office of Drug Control, Australian Biosecurity Import Conditions, and Department of Gene Technology Regulator. For pharmaceutical companies and CROs importing clinical materials.

6Secondary Packaging
CategoryClinical Trial Packaging Services
Description

TGA-licensed clinical trial packaging services including over-labelling, expiry extension, package insert management, re-packaging, bundling and kitting to GMP standards. For pharmaceutical companies conducting clinical trials.

7Cold Chain Management
CategoryCold Chain Management
Description

End-to-end cold chain management solutions for investigational medicinal products including temperature-controlled storage, validated freezer storage containers, liquid nitrogen storage, and temperature monitoring for full compliance and traceability. For pharmaceutical and biotech companies.

8Time & Temperature Sensitive Distribution
CategoryTemperature-Controlled Distribution
Description

Temperature-controlled logistics and distribution services maintaining specific temperature ranges (controlled ambient 15-25°C, refrigerated 2-8°C, frozen -20°C, dry ice -80°C, cryogenic LN2) during transport across Australia, Asia Pacific, America and Europe. For pharmaceutical companies, CROs, and biotech firms.

9Drug Return & Destruction
CategoryReverse Logistics Services
Description

Reverse logistics services managing collection of unused medication from supply chain points including patients and investigator sites, with cold chain maintenance during collection and proper destruction of controlled medicines with Certificate of Destruction. For pharmaceutical companies managing clinical trial returns.

10Pharmaceutical Storage
CategoryPharmaceutical Storage Services
Description

Secure and temperature-controlled pharmaceutical storage including controlled ambient (15-25°C) and security vault storage for highly regulated, temperature-sensitive products. For pharmaceutical companies and biotech firms.

Scale indicator4 records

Each record includes

Type, Value, Description, Source

Partnership3 partners
1ARCS
Strategic tierMinorTypeOthers
Description

ARCS (Australia) is listed as a partner organization on Cryosite's website. ARCS is an industry association for clinical research.

cryosite.com
Strategic tierMinorTypeOthers
Description

AusBiotech is listed as a partner organization on Cryosite's website. AusBiotech is Australia's biotechnology industry organization.

Strategic tierMinorTypeStrategic or Co-development Partner
Description

Cryosite acquired StemLife cord blood samples in 2016 and continues to store these samples long-term at their facility.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Biocair is a specialist life sciences logistics provider focused on clinical trial and pharmaceutical cold-chain distribution with strong APAC and global reach — directly comparable to Cryosite's clinical trial logistics and cold-chain services.

TypeDirect peer
Description

World Courier (part of Cencora/AmerisourceBergen) provides specialty pharmaceutical logistics including clinical trial storage, distribution, and cold-chain management — a direct competitor to Cryosite in clinical trial depot services with a globally larger depot network.

TypeBroad incumbent
Description

Almac Group provides integrated clinical trial supply services including packaging, distribution, and temperature-controlled storage as part of a broader pharmaceutical services portfolio — overlapping with Cryosite's secondary packaging and depot offerings but at a larger scale and broader scope.

TypeBroad incumbent
Description

DHL Supply Chain operates dedicated life sciences and clinical trial logistics networks with global cold-chain warehousing and GDP-compliant distribution — competing with Cryosite's clinical trial depot and cold-chain services as part of DHL's much broader logistics portfolio.

TypeDirect peer
Description

Azenta (formerly Brooks Life Sciences/BioStorage Technologies) operates biological sample storage, cryogenic storage, and biorepository services globally — a direct peer to Cryosite's biological and cryogenic storage business, with significantly larger global scale.

TypeBroad incumbent
Description

Clario provides clinical trial technology and supporting services including temperature monitoring and clinical logistics — competing with Cryosite in clinical trial depot and cold-chain monitoring services as part of a broader eClinical platform.

TypeDirect peer
Description

Cryoport provides temperature-controlled logistics and cryogenic shipping (LN2/vapor phase) for the life sciences industry, including cell and gene therapy supply chains — directly comparable to Cryosite's cryogenic storage and CGT depot services, with global scope and broader service portfolio.

TypeEmerging player
Description

Cell&Co provides bioservices including cell banking, biological sample storage, and cryopreservation services for biotech and cell therapy companies — a niche, emerging peer with overlapping biological and cryogenic storage capabilities to Cryosite.

TypeBroad incumbent
Description

Eurofins operates a global bioanalytical and biopharma services network that includes sample handling, storage, and cold-chain logistics — an adjacent competitor with overlapping biological sample storage capabilities though primarily focused on testing rather than depot services.

TypeDirect peer
Description

Marken (a UPS company) is a global clinical trial logistics specialist offering time- and temperature-sensitive supply chain services, cold-chain storage, and direct-to-patient distribution — directly comparable to Cryosite's core clinical trial depot and cold-chain business, with a larger global footprint.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Segment4 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature4 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles4 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

Subsidiaries1 record

Each record includes

Name, Acquired on, Relationship type, Type, Business focus

Compliance8 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Cryosite

Clinical Trial Logistics Servicescryosite.com

Cryosite Limited (ASX: CTE) is an Australian TGA-licensed clinical trial depot services provider offering multi-temperature storage, distribution, secondary packaging, and importer of record services to pharmaceutical companies, CROs, and biotechnology firms from its Sydney facility, with specialization in cryogenic storage for cell and gene therapies.

What Cryosite does

Cryosite Limited (ASX: CTE) is an Australian clinical trial depot services provider operating from a TGA-licensed, GMP-certified facility in South Granville, NSW. The company manages the end-to-end clinical trial supply chain for pharmaceutical companies, contract research organisations (CROs), and biotechnology firms, including importation of clinical materials, multi-temperature storage (controlled ambient 15–25°C, refrigerated 2–8°C, frozen -20°C, ultra-frozen -80°C, and cryogenic -196°C), distribution, secondary packaging, and reverse logistics including drug return and destruction. Cryosite operates one of Australia's largest single-site liquid nitrogen tank farms for cryogenic storage of cell and gene therapies, biological samples, and cell banks, supported by validated Warehouse Management and Quality Management Systems, 24/7 continuous temperature monitoring with automated alarm escalation, and RF barcode scanning for full chain-of-custody traceability. The company also retains a legacy cord blood storage portfolio from its origins as Australia's first private cord blood bank in 2000, including samples acquired from StemLife in 2016, though new cord blood collections ceased in 2017.

Cryosite generates revenue through managed-services contracts for clinical trial depot services and biological storage, supplemented by professional-services fees for importer of record work and TGA-licensed secondary packaging. Pricing is quote-based and tailored to client specifications rather than published on a tiered schedule. The company manages more than 6,000 shipments annually with a 99% on-time delivery rate and 90% temperature-controlled shipments, distributing across Australia, Asia Pacific, America, and Europe via carrier partnerships. Reported FY2026 unaudited financials show revenue of A$16.7 million and EBITDA of A$4.3 million, indicating profitable operations on a specialized-services base with a small headcount (11–50 employees).

The business is differentiated by a deep regulatory credential stack — TGA license, cGMP, PIC/S GMP, NSW Health wholesaler licensing, Department of Agriculture Approved Arrangement, and Australian cGMP for human blood, tissues, and cell therapies — which collectively raise barriers to entry for would-be depot competitors in the Australian market. Cryosite's go-to-market relies on direct B2B enterprise sales to pharma sponsors and CROs, supplemented by content marketing and industry association partnerships with ARCS and AusBiotech.

Cryosite firmographics

Firmographics
Name
Cryosite
Legal name
Cryosite Limited
Website
https://cryosite.com
Company type
Public
Founded year
2000
Operating status
Operating
Headcount range
11–50 employees
Short description
Cryosite Limited (ASX: CTE) is an Australian TGA-licensed clinical trial depot services provider offering multi-temperature storage, distribution, secondary packaging, and importer of record services to pharmaceutical companies, CROs, and biotechnology firms from its Sydney facility, with specialization in cryogenic storage for cell and gene therapies.
Ownership category
akta.pro rank

Cryosite industry classification

Industry
Product category
Clinical Trial Logistics Services
NAICS
Refrigerated Warehousing and Storage (493120)
SIC
Wholesale-Medical, Dental & Hospital Equipment & Supplies (5047), Services-Commercial Physical & Biological Research (8731)
akta.pro industry
PRIMARYTLAIAIAC
Clinical Trials & Investigational Product (IP) Cold Chain Logistics
SECONDARYHLAGAGAK
Cold Chain Storage & Cryopreservation Services (LN2/Ultra-low)
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Biopharma Manufacturing Services (Biologics/Cell & Gene)
SECONDARYHLAAAJAN
Cold Chain, Cryopreservation & Biologics Storage/Handling Technologies
Healthcare & Life Sciences/Biotechnology & Biologics/Bioprocessing & Biomanufacturing Technology (upstream/downstream, single-use, analytics)
SECONDARYTLADAHAJ
Cryogenic / Ultra-Low Temperature Transport (e.g., dry ice, LN2)
Transportation & Logistics/Freight Transportation (Air, Maritime, Rail, Trucking)/Refrigerated & Temperature-Controlled Freight Transport
SECONDARYTLACAMAM
Dry Ice & Cryogenic (LN2) Handling and Transport Services

Keywords

  • Clinical trial logistics
  • Biological storage services
  • Cryogenic storage
  • Cold chain management
  • Pharmaceutical depot services

Where Cryosite is headquartered

Location

Headquarters

HQ city
Granville
HQ country
Australia
HQ region
Oceania

Offices1 record

Markets served

Cryosite business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Operations, Infrastructure, Technology or R&D, Marketing or Sales

Revenue model

  1. Clinical Trial Depot Services: Outsourced clinical trial logistics services including storage, distribution, returns management, and destruction of investigational products
  2. Biological Storage Services: Cold, frozen, and cryogenic storage for biological materials including cord blood, cell banks, and tissue samples
  3. Importer of Record Services: Legal importation of clinical materials into Australia with permit applications support
  4. Secondary Packaging Services: TGA-licensed packaging services including re-labelling, re-packaging, and expiry extension

Go-to-market motion1 record

Distribution channels2 records

Marketing channels3 records

Cryosite product offering

Product offering

Core offering

Cryosite provides outsourced clinical trial depot services and biological storage from its TGA-licensed, GMP-certified facility in Sydney, Australia. The company manages the full clinical trial supply chain including importation, receipt, multi-temperature storage (controlled ambient, refrigerated, frozen, ultra-frozen, and cryogenic at -196°C), distribution, secondary packaging, and reverse logistics for pharmaceutical companies, CROs, and biotechnology firms. Additional services include cryogenic storage for cell and gene therapies, importer of record services, and drug return and destruction.

Product overview

Cryosite is a clinical trials depot services company operating as a specialized third-party logistics (3PL) provider for the life sciences and biotechnology industries. The company offers a unified portfolio of services centered around clinical trial supply chain management, encompassing clinical trial logistics, biological storage (including cryogenic liquid nitrogen storage), cell and gene therapies depot services, cold chain management, temperature-sensitive distribution, and secondary packaging. Additional services include importer of record, drug return & destruction, and legacy cord blood storage. The company operates from a TGA-licensed and GMP-certified facility in Sydney, Australia, managing over 6,000 shipments annually with 90% temperature-controlled.

Differentiator

Problem solved

Functional benefit

Products and services

  • Clinical Trial Logistics Services Specialised outsourced clinical trial logistics services managing the entire clinical trial supply chain from importation, receipt, ambient, cold, frozen, and liquid nitrogen storage for temperature-sensitive products, to distribution and reverse logistics management. Targeted at pharmaceutical companies, CROs, and biotechnology firms.
  • Biological Storage Frozen storage services for biological materials including cell banks (MCB, WCB), mesenchymal stromal cell therapies, TIL therapies, HPC therapies, vaccines, tissue samples, and blood products at various temperature ranges from -25°C to -196°C. For biotechnology and pharmaceutical companies.
  • Cell & Gene Therapies Depot Services Depot services specifically designed for cell and gene therapies, providing cryogenic storage, chain of custody management, and logistics support for these advanced therapeutic modalities. Targeted at biotechnology companies developing advanced therapies.
  • Liquid Nitrogen Storage Cryogenic liquid nitrogen storage solutions maintaining temperatures at -196°C for preserving biological materials, cell and gene therapies, with advanced cryogenic monitoring technology. For pharmaceutical, biotech, and research organisations.
  • Importer of Record Services Expert importer of record services ensuring legal importation of clinical materials into Australia, including permit applications for Office of Drug Control, Australian Biosecurity Import Conditions, and Department of Gene Technology Regulator. For pharmaceutical companies and CROs importing clinical materials.
  • Secondary Packaging TGA-licensed clinical trial packaging services including over-labelling, expiry extension, package insert management, re-packaging, bundling and kitting to GMP standards. For pharmaceutical companies conducting clinical trials.
  • Cold Chain Management End-to-end cold chain management solutions for investigational medicinal products including temperature-controlled storage, validated freezer storage containers, liquid nitrogen storage, and temperature monitoring for full compliance and traceability. For pharmaceutical and biotech companies.
  • Time & Temperature Sensitive Distribution Temperature-controlled logistics and distribution services maintaining specific temperature ranges (controlled ambient 15-25°C, refrigerated 2-8°C, frozen -20°C, dry ice -80°C, cryogenic LN2) during transport across Australia, Asia Pacific, America and Europe. For pharmaceutical companies, CROs, and biotech firms.
  • Drug Return & Destruction Reverse logistics services managing collection of unused medication from supply chain points including patients and investigator sites, with cold chain maintenance during collection and proper destruction of controlled medicines with Certificate of Destruction. For pharmaceutical companies managing clinical trial returns.
  • Pharmaceutical Storage Secure and temperature-controlled pharmaceutical storage including controlled ambient (15-25°C) and security vault storage for highly regulated, temperature-sensitive products. For pharmaceutical companies and biotech firms.

Quantifiable outcome

  • 99% on-time delivery for shipments
  • +2 more outcomes

Companies that use Cryosite

Customer profile

Segments4 records

Ideal customer profiles3 records

Cryosite technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature4 records

Cryosite partnerships and signals

Strategic signal

Partnerships

Three partnerships are on record, tiered minor.

  • ARCSminorOthersARCS (Australia) is listed as a partner organization on Cryosite's website. ARCS is an industry association for clinical research.
  • AusBiotechminorOthersAusBiotech is listed as a partner organization on Cryosite's website. AusBiotech is Australia's biotechnology industry organization.
  • StemLifeminorStrategic or Co-development PartnerCryosite acquired StemLife cord blood samples in 2016 and continues to store these samples long-term at their facility.

Scale indicators4 records

Recent moves6 records

Expansion highlights5 records

Cryosite competitors and assessment

Company assessment

Direct peers

  • Biocair: Biocair is a specialist life sciences logistics provider focused on clinical trial and pharmaceutical cold-chain distribution with strong APAC and global reach — directly comparable to Cryosite's clinical trial logistics and cold-chain services.
  • World Courier: World Courier (part of Cencora/AmerisourceBergen) provides specialty pharmaceutical logistics including clinical trial storage, distribution, and cold-chain management — a direct competitor to Cryosite in clinical trial depot services with a globally larger depot network.
  • Azenta Life Sciences: Azenta (formerly Brooks Life Sciences/BioStorage Technologies) operates biological sample storage, cryogenic storage, and biorepository services globally — a direct peer to Cryosite's biological and cryogenic storage business, with significantly larger global scale.
  • Cryoport Systems: Cryoport provides temperature-controlled logistics and cryogenic shipping (LN2/vapor phase) for the life sciences industry, including cell and gene therapy supply chains — directly comparable to Cryosite's cryogenic storage and CGT depot services, with global scope and broader service portfolio.
  • Marken: Marken (a UPS company) is a global clinical trial logistics specialist offering time- and temperature-sensitive supply chain services, cold-chain storage, and direct-to-patient distribution — directly comparable to Cryosite's core clinical trial depot and cold-chain business, with a larger global footprint.

Broad incumbents

  • Almac Group: Almac Group provides integrated clinical trial supply services including packaging, distribution, and temperature-controlled storage as part of a broader pharmaceutical services portfolio — overlapping with Cryosite's secondary packaging and depot offerings but at a larger scale and broader scope.
  • DHL Supply Chain (Life Sciences): DHL Supply Chain operates dedicated life sciences and clinical trial logistics networks with global cold-chain warehousing and GDP-compliant distribution — competing with Cryosite's clinical trial depot and cold-chain services as part of DHL's much broader logistics portfolio.
  • Clario (formerly Bioclinica): Clario provides clinical trial technology and supporting services including temperature monitoring and clinical logistics — competing with Cryosite in clinical trial depot and cold-chain monitoring services as part of a broader eClinical platform.
  • Eurofins BioPharma Product Testing: Eurofins operates a global bioanalytical and biopharma services network that includes sample handling, storage, and cold-chain logistics — an adjacent competitor with overlapping biological sample storage capabilities though primarily focused on testing rather than depot services.

Emerging players

  • Cell&Co BioServices: Cell&Co provides bioservices including cell banking, biological sample storage, and cryopreservation services for biotech and cell therapy companies — a niche, emerging peer with overlapping biological and cryogenic storage capabilities to Cryosite.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights6 records

Customer concentration

Cryosite social profiles

Digital presence

Cryosite compliance and trust

Trust signal

Compliance8 records

Cryosite financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Cryosite leadership team

Management profile

Number of profiles

Profiles4 records

Cryosite subsidiaries and ownership

Company hierarchy

Subsidiaries1 record

Cryosite funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Cryosite M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Cryosite

What does Cryosite do?

Cryosite provides outsourced clinical trial depot services and biological storage from its TGA-licensed, GMP-certified facility in Sydney, Australia. The company manages the full clinical trial supply chain including importation, receipt, multi-temperature storage (controlled ambient, refrigerated, frozen, ultra-frozen, and cryogenic at -196°C), distribution, secondary packaging, and reverse logistics for pharmaceutical companies, CROs, and biotechnology firms. Additional services include cryogenic storage for cell and gene therapies, importer of record services, and drug return and destruction.

Is Cryosite a public or private company?

Cryosite is a public company. It is classified as public and is currently operating.

When was Cryosite founded?

Cryosite was founded in 2000. It employs 11 to 50 people.

Where is Cryosite based?

Cryosite is headquartered in Granville, Australia, in the Oceania region.

How does Cryosite make money?

Four revenue lines are on record. Clinical Trial Depot Services are the primary driver. The others are biological Storage Services, importer of Record Services and secondary Packaging Services.

Who are Cryosite's main competitors?

Direct peers on record are Biocair, World Courier, Azenta Life Sciences, Cryoport Systems and Marken. Broad incumbents are Almac Group, DHL Supply Chain (Life Sciences), Clario (formerly Bioclinica) and Eurofins BioPharma Product Testing. Cell&Co BioServices is listed as an emerging player.

Does Cryosite have an API?

No public API is recorded for Cryosite.

What industry is Cryosite in?

Cryosite's product category is Clinical Trial Logistics Services. Its primary akta.pro industry code is TLAIAIAC, Clinical Trials & Investigational Product (IP) Cold Chain Logistics, with a secondary code of HLAGAGAK, Cold Chain Storage & Cryopreservation Services (LN2/Ultra-low). Its NAICS code is 493120 and its SIC code is 5047.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals